| scholarly article | Q13442814 |
| P50 | author | Liping Yu | Q55189535 |
| Kevin P Campbell | Q58144660 | ||
| Stanley F Nelson | Q90679187 | ||
| Takako Yoshida-Moriguchi | Q105623621 | ||
| P2093 | author name string | Mary E Anderson | |
| Hane Lee | |||
| Tobias Willer | |||
| Francesco Muntoni | |||
| David Venzke | |||
| Tamieka Whyte | |||
| P2860 | cites work | Missense mutations in β-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1) cause Walker-Warburg syndrome. | Q36731388 |
| Deciphering the glycosylome of dystroglycanopathies using haploid screens for lassa virus entry | Q37572562 | ||
| Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve alpha-dystroglycan. The role of a novel O-mannosyl-type oligosaccharide in the binding of alpha-dystroglycan with laminin | Q38349218 | ||
| Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies | Q42524150 | ||
| Editing of H2BC NMR spectra | Q46687439 | ||
| LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies. | Q47375901 | ||
| Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi | Q48334621 | ||
| Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE | Q24301093 | ||
| Demonstration of mammalian protein O-mannosyltransferase activity: coexpression of POMT1 and POMT2 required for enzymatic activity | Q24303491 | ||
| ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome | Q24316024 | ||
| Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of α-dystroglycan | Q24321692 | ||
| The protein kinase complement of the human genome | Q24324497 | ||
| A novel human beta1,3-N-acetylgalactosaminyltransferase that synthesizes a unique carbohydrate structure, GalNAcbeta1-3GlcNAc | Q28511795 | ||
| Improved spectral resolution in cosy 1H NMR spectra of proteins via double quantum filtering | Q29618846 | ||
| O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding. | Q34090655 | ||
| Like-acetylglucosaminyltransferase (LARGE)-dependent modification of dystroglycan at Thr-317/319 is required for laminin binding and arenavirus infection. | Q34223029 | ||
| Glycomic analyses of mouse models of congenital muscular dystrophy | Q35065134 | ||
| Dystroglycan: from biosynthesis to pathogenesis of human disease. | Q36367346 | ||
| Exome sequencing and functional validation in zebrafish identify GTDC2 mutations as a cause of Walker-Warburg syndrome | Q36439344 | ||
| Identification of mutations in TMEM5 and ISPD as a cause of severe cobblestone lissencephaly | Q36451494 | ||
| P433 | issue | 6148 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | glycosylation | Q898365 |
| carbohydrate phosphorylation | Q14863084 | ||
| Beta-1,3-N-acetylgalactosaminyltransferase 2 | Q21109542 | ||
| Protein O-mannose kinase | Q21121418 | ||
| Protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-) | Q21123155 | ||
| Protein-O-mannose kinase | Q21986759 | ||
| Protein O-linked mannose beta 1,4-N-acetylglucosaminyltransferase 2 | Q21990911 | ||
| P304 | page(s) | 896-899 | |
| P577 | publication date | 2013-08-08 | |
| P1433 | published in | Science | Q192864 |
| P1476 | title | SGK196 is a glycosylation-specific O-mannose kinase required for dystroglycan function | |
| P478 | volume | 341 |
| Q42506388 | 3D structural analysis of protein O-mannosyl kinase, POMK, a causative gene product of dystroglycanopathy. |
| Q29347528 | A POGLUT1 mutation causes a muscular dystrophy with reduced Notch signaling and satellite cell loss. |
| Q24338170 | A Single Kinase Generates the Majority of the Secreted Phosphoproteome |
| Q90362813 | A new patient-derived iPSC model for dystroglycanopathies validates a compound that increases glycosylation of α-dystroglycan |
| Q37646939 | A novel missense mutation in POMT1 modulates the severe congenital muscular dystrophy phenotype associated with POMT1 nonsense mutations. |
| Q34376382 | A robust methodology to subclassify pseudokinases based on their nucleotide-binding properties |
| Q28511766 | AGO61-dependent GlcNAc modification primes the formation of functional glycans on α-dystroglycan |
| Q48021354 | Analysis of phenotype, enzyme activity and genotype of Chinese patients with POMT1 mutation |
| Q50296375 | B3GALNT2 transfers GalNAc to GlcNAc-Man-DAG1 |
| Q24305043 | B4GAT1 is the priming enzyme for the LARGE-dependent functional glycosylation of α-dystroglycan |
| Q89047205 | CDP-glycerol inhibits the synthesis of the functional O-mannosyl glycan of α-dystroglycan |
| Q37200133 | Carbohydrate-binding domain of the POMGnT1 stem region modulates O-mannosylation sites of α-dystroglycan |
| Q33930289 | Comparative Analysis of Protein Glycosylation Pathways in Humans and the Fungal Pathogen Candida albicans |
| Q36275198 | Comprehensive target capture/next-generation sequencing as a second-tier diagnostic approach for congenital muscular dystrophy in Taiwan |
| Q34149744 | Contribution of dysferlin deficiency to skeletal muscle pathology in asymptomatic and severe dystroglycanopathy models: generation of a new model for Fukuyama congenital muscular dystrophy |
| Q92711724 | Crystal structures of fukutin-related protein (FKRP), a ribitol-phosphate transferase related to muscular dystrophy |
| Q52150565 | Degree of Cajal-Retzius Cell Mislocalization Correlates with the Severity of Structural Brain Defects in Mouse Models of Dystroglycanopathy. |
| Q42687793 | Direct Mapping of Additional Modifications on Phosphorylated O-glycans of α-Dystroglycan by Mass Spectrometry Analysis in Conjunction with Knocking Out of Causative Genes for Dystroglycanopathy |
| Q37609175 | Dissecting the molecular basis of the role of the O-mannosylation pathway in disease: α-dystroglycan and forms of muscular dystrophy |
| Q35899912 | Downregulation of dystroglycan glycosyltransferases LARGE2 and ISPD associate with increased mortality in clear cell renal cell carcinoma. |
| Q41987606 | Dystroglycan binding to α-neurexin competes with neurexophilin-1 and neuroligin in the brain. |
| Q35709549 | Ectopic clustering of Cajal-Retzius and subplate cells is an initial pathological feature in Pomgnt2-knockout mice, a model of dystroglycanopathy. |
| Q92058699 | Elimination of fukutin reveals cellular and molecular pathomechanisms in muscular dystrophy-associated heart failure |
| Q24302249 | Endogenous glucuronyltransferase activity of LARGE or LARGE2 required for functional modification of α-dystroglycan in cells and tissues |
| Q48376449 | Evidence of early defects in Cajal-Retzius cell localization during brain development in a mouse model of dystroglycanopathy. |
| Q37578908 | Evolution of protein N-glycosylation process in Golgi apparatus which shapes diversity of protein N-glycan structures in plants, animals and fungi |
| Q64359271 | Exploitation of glycosylation in enveloped virus pathobiology |
| Q49685437 | Expression in retinal neurons of fukutin and FKRP, the protein products of two dystroglycanopathy-causative genes |
| Q50492920 | Expression of glycosylated α-dystroglycan in newborn skeletal and cardiac muscles of fukutin related protein (FKRP) mutant mice. |
| Q38219649 | Extracellular O-linked β-N-acetylglucosamine: Its biology and relationship to human disease |
| Q64329469 | Facile Chemoenzymatic Synthesis of O-Mannosyl Glycans |
| Q38240078 | Finding the sweet spot: assembly and glycosylation of the dystrophin-associated glycoprotein complex |
| Q35062311 | Fukutin is prerequisite to ameliorate muscular dystrophic phenotype by myofiber-selective LARGE expression |
| Q36806841 | Global serum glycoform profiling for the investigation of dystroglycanopathies & Congenital Disorders of Glycosylation |
| Q100762161 | Global view of human protein glycosylation pathways and functions |
| Q26765063 | Glycan Engineering for Cell and Developmental Biology |
| Q38266217 | Glycobiology of α-dystroglycan and muscular dystrophy |
| Q38307398 | Going for broke: targeting the human cancer pseudokinome |
| Q39886001 | Golgi phosphoprotein 3 mediates the Golgi localization and function of protein O-linked mannose β-1,2-N-acetlyglucosaminyltransferase 1. |
| Q90154126 | HNK-1 Sulfotransferase modulates α-dystroglycan glycosylation by 3-O-sulfation of glucuronic acid on matriglycan |
| Q28080327 | Hunting Viral Receptors Using Haploid Cells |
| Q36919737 | ISPD produces CDP-ribitol used by FKTN and FKRP to transfer ribitol phosphate onto α-dystroglycan |
| Q92537294 | Identification of mammalian glycoproteins with type-I LacdiNAc structures synthesized by the glycosyltransferase B3GALNT2 |
| Q35002856 | Impaired O-linked N-acetylglucosaminylation in the endoplasmic reticulum by mutated epidermal growth factor (EGF) domain-specific O-linked N-acetylglucosamine transferase found in Adams-Oliver syndrome. |
| Q35400504 | Intrafamilial variability in GMPPB-associated dystroglycanopathy: Broadening of the phenotype |
| Q37472546 | LARGE2-dependent glycosylation confers laminin-binding ability on proteoglycans. |
| Q90362150 | Laminin G-like domains: dystroglycan-specific lectins |
| Q39032336 | Lassa Virus Cell Entry Reveals New Aspects of Virus-Host Cell Interaction |
| Q92003945 | Life is sweet: the cell biology of glycoconjugates |
| Q64233103 | Mammalian O-mannosyl glycans: Biochemistry and glycopathology |
| Q33882060 | Mammalian O-mannosylation of cadherins and plexins is independent of protein O-mannosyltransferases 1 and 2. |
| Q38208557 | Mammalian O-mannosylation pathway: glycan structures, enzymes, and protein substrates |
| Q38424785 | Matriglycan: a novel polysaccharide that links dystroglycan to the basement membrane. |
| Q51503611 | Methods to Purify and Assay Secretory Pathway Kinases. |
| Q36738591 | Milder forms of muscular dystrophy associated with POMGNT2 mutations |
| Q37421355 | Mining the O-mannose glycoproteome reveals cadherins as major O-mannosylated glycoproteins |
| Q47168266 | Muscular Dystrophy with Ribitol-Phosphate Deficiency: A Novel Post-Translational Mechanism in Dystroglycanopathy |
| Q92267937 | Myo-Glyco disease Biology: Genetic Myopathies Caused by Abnormal Glycan Synthesis and Degradation |
| Q35451121 | Neurons and glia modify receptor protein-tyrosine phosphatase ζ (RPTPζ)/phosphacan with cell-specific O-mannosyl glycans in the developing brain |
| Q56833662 | New tools for carbohydrate sulfation analysis: heparan sulfate 2--sulfotransferase (HS2ST) is a target for small-molecule protein kinase inhibitors |
| Q39005429 | Overexpression of LARGE suppresses muscle regeneration via down-regulation of insulin-like growth factor 1 and aggravates muscular dystrophy in mice |
| Q50296374 | POMGNT2 transfers GlcNAc to Man-DAG1 |
| Q50296376 | POMK 6-phosphorylates Mannose in GalNAc-GlcNAc-Man-DAG1 |
| Q46926225 | POMK mutation in a family with congenital muscular dystrophy with merosin deficiency, hypomyelination, mild hearing deficit and intellectual disability |
| Q30590282 | POMK mutations disrupt muscle development leading to a spectrum of neuromuscular presentations |
| Q99716328 | POMK regulates dystroglycan function via LARGE-mediated elongation of matriglycan |
| Q88238536 | Perspectives on Glycosylation and Its Congenital Disorders |
| Q37040656 | Phosphorylation of spore coat proteins by a family of atypical protein kinases. |
| Q38214809 | Precision genome editing: a small revolution for glycobiology. |
| Q92237404 | Prospects for pharmacological targeting of pseudokinases |
| Q46448834 | Protein O-Linked Mannose β-1,4-N-Acetylglucosaminyl-transferase 2 (POMGNT2) Is a Gatekeeper Enzyme for Functional Glycosylation of α-Dystroglycan |
| Q37698536 | Protein O-mannosylation in metazoan organisms |
| Q40657565 | Protein O-mannosylation is crucial for human mesencyhmal stem cells fate. |
| Q35413473 | Protein glycosylation in cancer |
| Q40092479 | Recent advancements in understanding mammalian O-mannosylation |
| Q90438803 | Ribitol enhances matriglycan of α-dystroglycan in breast cancer cells without affecting cell growth |
| Q58701413 | Ribitol restores functionally glycosylated α-dystroglycan and improves muscle function in dystrophic FKRP-mutant mice |
| Q34469573 | Secretome analysis identifies novel signal Peptide peptidase-like 3 (Sppl3) substrates and reveals a role of Sppl3 in multiple Golgi glycosylation pathways |
| Q112700782 | Small RNAs are modified with N-glycans and displayed on the surface of living cells |
| Q38186249 | Solving glycosylation disorders: fundamental approaches reveal complicated pathways |
| Q31121747 | Structural basis of laminin binding to the LARGE glycans on dystroglycan |
| Q52639394 | Structure and evolution of the Fam20 kinases. |
| Q37482125 | Structure of protein O-mannose kinase reveals a unique active site architecture. |
| Q32884430 | The Muscular Dystrophy Gene TMEM5 Encodes a Ribitol β1,4-Xylosyltransferase Required for the Functional Glycosylation of Dystroglycan |
| Q28546951 | The Structure of the T190M Mutant of Murine α-Dystroglycan at High Resolution: Insight into the Molecular Basis of a Primary Dystroglycanopathy |
| Q41820882 | The evolution of the dystroglycan complex, a major mediator of muscle integrity |
| Q32884479 | The functional O-mannose glycan on α-dystroglycan contains a phospho-ribitol primed for matriglycan addition |
| Q24305058 | The glucuronyltransferase B4GAT1 is required for initiation of LARGE-mediated α-dystroglycan functional glycosylation |
| Q28085305 | The secretory pathway kinases |
| Q98163745 | The ties that bind: functional clusters in limb-girdle muscular dystrophy |
| Q39314908 | The transgenic expression of LARGE exacerbates the muscle phenotype of dystroglycanopathy mice |
| Q57562533 | Third International Workshop for Glycosylation Defects in Muscular Dystrophies, 18-19 April 2013, Charlotte, USA |
| Q28115432 | Xylose phosphorylation functions as a molecular switch to regulate proteoglycan biosynthesis |
Search more.